Exponent (EXPO) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.46 per share a year ago. These figures are ...

Scientific consulting firm Exponent (NASDAQ:EXPO) reported in Q4 CY2025, with sales up 19.1% year on year to $147.4 million.

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future ...

Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. "We delivered a ...

Optimas provides distribution and supply chain management services, of “mission-critical” fasteners and c-class components.

The company’s third-quarter results in October offered encouragement, with earnings of $0.55 per share beating expectations of $0.51 and revenue of $147.1 million surpassing forecasts by nearly 12%.

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Exponent (EXPO) recently reported third quarter earnings and revenue that came in ahead of expectations, a result that coincided with analyst upgrades and a more upbeat tone from management regarding ...